Market Business Insights Medical Device Outsourced Manufacturing Market
Request Sample Buy Now

Report Description

Premium Insight

The global medical device outsourced manufacturing market is expected to experience significant growth in the forecast period. According to market research, the revenue is expected to reach 29300 USD Million by 2022 and 56200 USD Million by 2030, with a Compound Annual Growth Rate (CAGR) of 13.9%.

The market is segmented into In Vitro Diagnostic (IVD) devices, drug delivery devices, diabetes care devices, cardiovascular devices, and others. The IVD devices segment is expected to hold the largest share of 35%, followed by drug delivery devices with a share of 25%, diabetes care devices with 10%, and cardiovascular devices with 10%. Other devices including surgical instruments and patient monitoring devices are expected to hold a share of 20%.

Several prominent companies in the market include Wipro GE Healthcare, Johari Digital, Johnson & Johnson, Novartis AG, Medtronic India Pvt. Ltd., Sterilmed, Sterigenics, 3M and BD. These companies are investing in developing advanced technologies and expanding their product portfolios to gain a competitive edge in the market. In addition, they are also focusing on mergers and acquisitions to strengthen their market position and increase their product offerings.

North America is expected to dominate the market due to the presence of several leading manufacturers in the region and favorable government initiatives to promote healthcare infrastructure. The Asia-Pacific region is expected to exhibit the highest growth rate due to the increasing demand for medical devices and rapid advancement of healthcare infrastructure in emerging economies like India, China, and Japan.

In conclusion, the global medical device outsourced manufacturing market is expected to witness significant growth in the upcoming years, with IVD devices and drug delivery devices expected to hold the largest shares. Several prominent companies are investing in developing advanced technologies, expanding their product portfolios, and focusing on mergers and acquisitions to gain a competitive edge.

Economic Insight

The medical device outsourced manufacturing market is experiencing significant growth due to various factors, including the rise in chronic diseases, aging population, and advancements in healthcare technology. The segment with the largest share in this market is In Vitro Diagnostic (IVD) devices, followed by drug delivery devices and diabetes care devices. This indicates the importance of diagnostic and therapeutic devices in the healthcare industry.

Moreover, the market is projected to have a CAGR of 13.9%, which portrays a steady growth rate. This is attributed to the increasing demand for medical devices, especially in emerging markets. Furthermore, technological advancements in medical devices manufacturing are expected to boost the growth rate of the market.

In terms of companies operating in this market, Wipro GE Healthcare, Johari Digital, Johnson & Johnson, Novartis AG, Medtronic India Pvt. Ltd., Sterilmed, Sterigenics, 3M, and BD are the key players. These companies are investing heavily in R&D activities to provide innovative solutions in the medical device manufacturing market and gain a competitive advantage.

The global medical device outsourced manufacturing market is expected to generate revenue of USD 29300 million in 2022, and this is projected to increase to USD 56200 million by 2030. This reflects the potential of this market to be a lucrative business opportunity for companies operating in the healthcare industry.

Furthermore, the increasing demand for medical devices in emerging markets, coupled with the rise in chronic diseases, is expected to drive the market's growth. This presents an opportunity for companies to expand their presence and tap into new markets, thereby increasing their revenue and profitability.

Medical Device Outsourced Manufacturing Market Segmentation

The Medical Device Outsourced Manufacturing Market can be segmented into the following categories based on the types of devices being manufactured:

1. In Vitro Diagnostic (IVD) devices: This segment includes devices such as diagnostic test kits, reagents, and laboratory instruments. As per the given data, this segment accounts for 35% of the total market share.

2. Drug delivery devices: This segment includes devices such as inhalers, syringes, and pumps used to administer drugs. It accounts for a 25% share of the market.

3. Diabetes care devices: This segment includes devices such as insulin pumps, continuous glucose monitoring systems, and blood glucose meters. As per the given data, it accounts for a 10% share of the market.

4. Cardiovascular devices: This segment includes devices such as pacemakers, stents, and heart valves. As per the given data, it accounts for a 10% share of the market.

5. Others: This segment includes devices such as orthopedic implants, surgical instruments, and imaging equipment. It accounts for a 20% share of the market.

Based on the given data, the IVD devices segment is the largest segment, followed by drug delivery devices. The diabetes care devices and cardiovascular devices segments are equally significant, while the others segment is relatively smaller. Overall, all the segments of the Medical Device Outsourced Manufacturing Market are experiencing growth and are expected to continue to do so in the coming years.

Top Market Trends

The medical device outsourced manufacturing market is expected to witness strong growth in the coming years, driven by several key market trends. Here are some of the top market trends:

1. Growing Demand for Medical Devices: As healthcare spending continues to increase, the demand for innovative medical devices is also rising. This is expected to drive demand for outsourced manufacturing services, as companies seek to reduce costs and improve efficiency.

2. Increasing Focus on Quality Control: With the rising importance of medical devices, there is a greater emphasis on quality control and regulatory compliance. As a result, outsourcing partners are expected to play an increasingly important role in ensuring quality and compliance.

3. Technology Advancements: The development of new technologies such as 3D printing and IoT is expected to drive innovation in the medical device industry. This, in turn, is expected to lead to more complex devices and increase demand for specialized outsourced manufacturing services.

4. Favorable Regulatory Environment: The medical device industry is highly regulated, and companies face a complex regulatory landscape. However, recent regulatory changes have sought to reduce the burden on manufacturers, which could lead to increased outsourcing.

5. Increasing Adoption of Remote Monitoring Devices: There is a growing trend towards remote monitoring devices, which allow patients to manage their health remotely. This is expected to drive demand for specialized outsourced manufacturing services, as these devices require complex electronics and software.

6. Growing Popularity of Wearable Devices: Wearable devices are becoming increasingly popular in the healthcare sector, as they improve patient outcomes and enable providers to collect real-time data. This is expected to drive demand for outsourced manufacturing services, as wearable devices require specialized expertise in design and manufacturing.

In conclusion, the medical device outsourced manufacturing market is expected to experience strong growth in the coming years, driven by rising demand, increasing focus on quality control, technological advancements, favorable regulatory environment, increasing adoption of remote monitoring and wearable devices. As a result, companies such as Wipro GE Healthcare, Johari Digital, Johnson & Johnson, Novartis AG, Medtronic India Pvt. Ltd., Sterilmed, Sterigenics, 3M and BD are well positioned to benefit from these trends.

Competitive Landscape

The Medical Device Outsourced Manufacturing market is highly competitive, with several global and regional players operating in the market. The market is expected to grow at a CAGR of 13.9% from 2022 to 2030, and this growth is attracting more players to the market.

Some of the key players in the market are Wipro GE Healthcare, Johari Digital, Johnson & Johnson, Novartis AG, Medtronic India Pvt. Ltd., Sterilmed, Sterigenics, 3M, and BD. These companies are continuously investing in research and development efforts to develop new and innovative medical devices to gain a competitive edge in the market.

Wipro GE Healthcare is one of the leading players in the market, offering a wide range of medical devices, including imaging systems, diagnostics, and healthcare IT solutions. Johari Digital is another prominent player in the market, offering digital medical devices and healthcare solutions. Johnson & Johnson is a well-known player in the medical device industry, offering a diverse portfolio of medical devices, pharmaceutical, and consumer health products.

Other key players in the market include Novartis AG, a leading pharmaceutical company offering medical devices and drugs for various diseases and Medtronic India Pvt. Ltd., a global player offering a wide range of medical devices in various therapeutic areas. Sterilmed and Sterigenics are leading players in the medical device sterilization industry, while 3M and BD are leading players in the healthcare industry, offering a diverse range of medical products.

Overall, the competitive landscape of the Medical Device Outsourced Manufacturing market is expected to remain highly competitive, with key players continuously investing in research and development efforts to develop new and innovative medical devices and gain a competitive edge in the market.

Recent Developments

The medical device outsourced manufacturing market has witnessed significant growth in recent years due to the increasing demand for high-quality medical devices, the growing geriatric population, rising prevalence of chronic diseases, and the advancement of technology. The market is expected to continue to grow at a CAGR of 13.9% from 2022 to 2030, with a projected revenue of 56,200 USD Million by 2030.

One of the significant developments in the market is the increasing demand for in vitro diagnostics (IVD) devices, which are expected to hold a share of 35% in the market. The rising prevalence of chronic diseases and the need for accurate and rapid diagnosis have propelled the demand for IVD devices, leading to an increase in the manufacturing of these devices.

Another development in the market is the growing demand for diabetes care devices, with a projected share of 10%. The increasing prevalence of diabetes worldwide has led to a surge in the demand for devices such as insulin pumps, glucose monitoring systems, and insulin pens. The rising adoption of minimally invasive procedures has also contributed to the market's growth.

Moreover, the market is witnessing increasing investments in research and development, product innovation, strategic collaborations, and mergers and acquisitions. For instance, in 2019, Medtronic India Pvt. Ltd. launched a new insulin pump, the MiniMed 630G system, designed for patients with diabetes.

In addition, the market is highly competitive, with a large number of players operating in the market. Some of the prominent companies include Wipro GE Healthcare, Johari Digital, Johnson & Johnson, Novartis AG, Medtronic India Pvt. Ltd., Sterilmed, Sterigenics, 3M, and BD. These companies are focused on expanding their product portfolio, enhancing their manufacturing capabilities, and maintaining a strong presence in the market.

In conclusion, the medical device outsourced manufacturing market is expected to continue witnessing significant growth due to increasing demand, increasing investments, and collaborations between industry players. The rising prevalence of chronic diseases, aging population, and technological advancements will continue to drive growth in the market.

Report Coverage

Companies Covered
  • Wipro GE Healthcare
  • Johari Digital
  • Johnson & Johnson
  • Novartis AG
  • Medtronic India Pvt. Ltd.
  • Sterilmed
  • Sterigenics
  • 3M
  • BD

Above list is not exhaustive, you can add required companies.
Segments Covered
  • In Vitro Diagnostic (IVD) devices
    • Immunoassays
    • Molecular diagnostics
    • Other IVD devices
  • Drug delivery devices
    • Injectable devices
    • Implantable devices
    • Other drug delivery devices
  • Diabetes care devices
    • Insulin pumps
    • Glucose monitoring devices

Segment can be customized. You can ask for customization.
Purchase Option Avail of customized purchase options to meet your exact research needs. Explore purchase options

Medical Device Outsourced Manufacturing Report FAQ

The Medical Device Outsourced Manufacturing market is expected to be worth USD XX billion in 2022, rising at a CAGR of XX percent to USD XX billion by 2030.
Globally established firms such as dominate the Medical Device Outsourced Manufacturing market. To gain traction in this increasing Medical Device Outsourced Manufacturing industry, these organisations focus on producing new goods, implementing expansion plans, and engaging in collaboration...
Medical Device Outsourced Manufacturing Market production remained significantly disrupted by the COVID-19 pandemic. The global production of Medical Device Outsourced Manufacturing pre-COVID was expected to grow from XX million units in 2020 to XX million units by 2025, with the major markets in the applicat...
When the lockdown Medical Device Outsourced Manufacturing market is released, the market will make up for the losses it has sustained by 2024.
During the projection period, the worldwide Medical Device Outsourced Manufacturing market is expected to see a significant growth in demand for residential applications.
The global Medical Device Outsourced Manufacturing market is divided into three categories: type, application, and region.

We Accept
Select License
Includes
  • Purchase Report Sections
  • Regional analysis
  • Segmentation analysis
  • Industry outlook
  • Competitive landscape
Latest Reports